Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2017, Article ID 2879495, 9 pages
https://doi.org/10.1155/2017/2879495
Research Article

Protective Effects of an Ancient Chinese Kidney-Tonifying Formula against H2O2-Induced Oxidative Damage to MES23.5 Cells

1Second People’s Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province 350003, China
2Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province 350122, China
3Longyan First Hospital Affiliated to Fujian Medical University, Longyan, Fujian Province 364000, China
4Tibet Autonomous Region People’s Hospital, Lhasa, Tibet Autonomous Region 850000, China
5College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province 350122, China
6Graduate School, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province 350122, China
7Quanzhou Orthopedic-Traumatological Hospital, Fujian University of Traditional Chinese Medicine, Quanzhou, Fujian Province 362000, China
8School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

Correspondence should be addressed to Jing Cai; moc.361@1jiac

Received 11 August 2016; Accepted 27 December 2016; Published 12 March 2017

Academic Editor: Jin-Tai Yu

Copyright © 2017 Yihui Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fahn and G. Cohen, “The oxidant stress hypothesis in Parkinson's disease: evidence supporting it,” Annals of Neurology, vol. 32, no. 6, pp. 804–812, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Jenner and C. W. Olanow, “Oxidative stress and the pathogenesis of Parkinson's disease,” Neurology, vol. 47, supplement 3, pp. S161–S170, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Akaneya, M. Takahashi, and H. Hatanaka, “Involvement of free radicals in MPP+ neurotoxicity against rat dopaminergic neurons in culture,” Neuroscience Letters, vol. 193, no. 1, pp. 53–56, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Emerit, M. Edeas, and F. Bricaire, “Neurodegenerative diseases and oxidative stress,” Biomedicine & Pharmacotherapy, vol. 58, no. 1, pp. 39–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. Chinese Pharmacopoeial Commission, Pharmacopoeia of the Peoples Republic of China, vol. 1, People's Medical Publishing House, Beijing, China, 2010.
  6. J. Cai, Y. Tian, R. Lin, X. Chen, Z. Liu, and J. Xie, “Protective effects of kidney-tonifying Chinese herbal preparation on substantia nigra neurons in a mouse model of Parkinson's disease,” Neural Regeneration Research, vol. 7, no. 6, pp. 413–420, 2012. View at Google Scholar · View at Scopus
  7. W. W. Li, R. Yang, and D. F. Cai, “Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 28, no. 3, pp. 248–251, 2008. View at Google Scholar
  8. W. Wei and C. Jing, “An analysis of TCM pattern and formula for parkinson's disease,” Journal of Traditional Chinese Medicine, vol. 54, no. 20, pp. 1778–1782, 2013. View at Google Scholar
  9. Y. Tian, J. Cai, and X. Chen, “Protection of kidney-tonifying Chinese herb on the nigra striatal neurons mice with Parkinson's disease,” Chinese Journal of Gerontology, vol. 31, no. 3, pp. 440–443, 2011. View at Google Scholar
  10. S. G. Lin, S. F. Ye, J. M. Huang et al., “How do Chinese medicines that tonify the kidney inhibit dopaminergic neuron apoptosis?” Neural Regeneration Research, vol. 8, no. 30, pp. 2820–2826, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Wang, W.-W. Li, D.-F. Cai, and R. Yang, “Protecting effect of Cistanche extracts on MPP+-induced injury of the Parkinson's disease cell model,” Journal of Chinese Integrative Medicine, vol. 5, no. 4, pp. 407–411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Geng, X. Tian, P. Tu, and X. Pu, “Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease,” European Journal of Pharmacology, vol. 564, no. 1–3, pp. 66–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-F. Tian and X.-P. Pu, “Phenylethanoid glycosides from Cistanches salsa inhibit apoptosis induced by 1-methyl-4-phenylpyridinium ion in neurons,” Journal of Ethnopharmacology, vol. 97, no. 1, pp. 59–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Geng, L. Song, X. Pu, and P. Tu, “Neuroprotective effects of phenylethanoid glycosides from Cistanches salsa against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice,” Biological and Pharmaceutical Bulletin, vol. 27, no. 6, pp. 797–801, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. S. Wong and K. M. Ko, “Herba Cistanches stimulates cellular glutathione redox cycling by reactive oxygen species generated from mitochondrial respiration in H9c2 cardiomyocytes,” Pharmaceutical Biology, vol. 51, no. 1, pp. 64–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Wing Sze, Y. Tong, T. B. Ng, C. L. Yin Cheng, and H. P. Cheung, “Herba Epimedii: anti-oxidative properties and its medical implications,” Molecules, vol. 15, no. 11, pp. 7861–7870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Trachootham, W. Lu, M. A. Ogasawara, N. R.-D. Valle, and P. Huang, “Redox regulation of cell survival,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Moore, A. B. West, V. L. Dawson, and T. M. Dawson, “Molecular pathophysiology of Parkinson's disease,” Annual Review of Neuroscience, vol. 28, pp. 57–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Sian, D. T. Dexter, A. J. Lees et al., “Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia,” Annals of Neurology, vol. 36, no. 3, pp. 348–355, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Halliwell and J. M. C. Gutteridge, “Role of free radic in human diseases: an overview,” Methods in Enzymology, vol. 186, pp. 1–85, 1990. View at Google Scholar
  21. K. Venderova and D. S. Park, “Programmed cell death in Parkinson's disease,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 8, Article ID a009365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Fridovich, “Fundamental aspects of reactive oxygen species, or what's the matter with oxygen?” Annals of the New York Academy of Sciences, vol. 893, pp. 13–18, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Xiong, S. Kadota, T. Tani, and T. Namba, “Antioxidative effects of phenylethanoids from Cistanche deserticola,” Biological and Pharmaceutical Bulletin, vol. 19, no. 12, pp. 1580–1585, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Koppula, H. Kumar, S. V. More, H.-W. Lim, S.-M. Hong, and D.-K. Choi, “Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease,” Molecules, vol. 17, no. 10, pp. 11391–11420, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Fang and Y. Wang, “Effect of isatin on the activities of antioxidase in PD model mice,” China Pharmacy, vol. 19, no. 22, pp. 1696–1697, 2008. View at Google Scholar